RVMD
Price
$64.37
Change
-$1.46 (-2.22%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
12.73B
109 days until earnings call
Intraday BUY SELL Signals
URGN
Price
$23.94
Change
-$1.20 (-4.77%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
1.18B
119 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RVMD vs URGN

Header iconRVMD vs URGN Comparison
Open Charts RVMD vs URGNBanner chart's image
Revolution Medicines
Price$64.37
Change-$1.46 (-2.22%)
Volume$42.67K
Capitalization12.73B
UroGen Pharma
Price$23.94
Change-$1.20 (-4.77%)
Volume$20.93K
Capitalization1.18B
RVMD vs URGN Comparison Chart in %
RVMD
Daily Signal:
Gain/Loss:
URGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RVMD vs. URGN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVMD is a Buy and URGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (RVMD: $65.83 vs. URGN: $25.14)
Brand notoriety: RVMD and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVMD: 121% vs. URGN: 98%
Market capitalization -- RVMD: $12.73B vs. URGN: $1.18B
RVMD [@Biotechnology] is valued at $12.73B. URGN’s [@Biotechnology] market capitalization is $1.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVMD’s FA Score shows that 0 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • RVMD’s FA Score: 0 green, 5 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both RVMD and URGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVMD’s TA Score shows that 3 TA indicator(s) are bullish while URGN’s TA Score has 6 bullish TA indicator(s).

  • RVMD’s TA Score: 3 bullish, 4 bearish.
  • URGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, URGN is a better buy in the short-term than RVMD.

Price Growth

RVMD (@Biotechnology) experienced а +10.94% price change this week, while URGN (@Biotechnology) price change was +30.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

RVMD is expected to report earnings on Mar 02, 2026.

URGN is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($12.7B) has a higher market cap than URGN($1.18B). URGN YTD gains are higher at: 136.056 vs. RVMD (50.503). URGN has higher annual earnings (EBITDA): -119.79M vs. RVMD (-883.71M). RVMD has more cash in the bank: 2.14B vs. URGN (196M). URGN has less debt than RVMD: URGN (125M) vs RVMD (133M). URGN has higher revenues than RVMD: URGN (91.9M) vs RVMD (0).
RVMDURGNRVMD / URGN
Capitalization12.7B1.18B1,079%
EBITDA-883.71M-119.79M738%
Gain YTD50.503136.05637%
P/E RatioN/AN/A-
Revenue091.9M-
Total Cash2.14B196M1,090%
Total Debt133M125M106%
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RVMDURGN
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 23 days ago
77%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
RVMD
Daily Signal:
Gain/Loss:
URGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SBIT34.820.84
+2.47%
ProShares UltraShort Bitcoin ETF
RODM36.490.19
+0.52%
Hartford Multifactor Dev Mkts (exUS) ETF
ITAN36.310.11
+0.29%
Sparkline Intangible Value ETF
BJAN53.82-0.01
-0.03%
Innovator US Equity Buff ETF™ Jan
IDEF30.88-0.14
-0.47%
iShares Defense Industrials Active ETF

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+2.73%
NUVL - RVMD
62%
Loosely correlated
+0.91%
OCUL - RVMD
53%
Loosely correlated
+2.41%
NRIX - RVMD
53%
Loosely correlated
-5.37%
CGON - RVMD
52%
Loosely correlated
+1.47%
ROIV - RVMD
52%
Loosely correlated
+2.01%
More

URGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, URGN has been loosely correlated with AIM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
+6.39%
AIM - URGN
39%
Loosely correlated
+0.32%
CYYNF - URGN
38%
Loosely correlated
N/A
RVMD - URGN
36%
Loosely correlated
+2.73%
PHAT - URGN
34%
Loosely correlated
+1.81%
VYGR - URGN
34%
Loosely correlated
-0.23%
More